Healthcare -
Biotechnology - NASDAQ - US
$ 8.01
-0.497 %
$ 1.26 B
Market Cap
-6.21
P/E
OCUL - LONG-TERM DEBT
Long-term Debt OCUL - Ocular Therapeutix, Inc.
81.8 M
LAST VALUE
19.42%
2 YEAR CAGR
26.97%
5 YEAR CAGR
62.15%
10 YEAR CAGR